U.S. markets closed

AcelRx Pharmaceuticals, Inc. (ACRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.9900-0.1100 (-5.24%)
At close: 04:00PM EST
2.0800 +0.09 (+4.52%)
After hours: 04:25PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.1000
Bid2.0600 x 1300
Ask2.1200 x 800
Day's Range1.9900 - 2.1500
52 Week Range1.7600 - 10.2000
Avg. Volume177,060
Market Cap16.314M
Beta (5Y Monthly)0.26
PE Ratio (TTM)0.33
EPS (TTM)6.0700
Earnings DateMar 08, 2023 - Mar 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est80.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
195% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ACRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AcelRx Pharmaceuticals, Inc.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • Insider Monkey

    AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call Transcript

    AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q3 2022 Earnings Call Transcript November 14, 2022 AcelRx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.2. Operator: Welcome to the AcelRx Third Quarter 2022 Earnings Call. This call is being webcast live via the Events page of the Investors section of AcelRx’s website at This […]

  • PR Newswire

    AcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock

    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced it has entered into an agreement with a life sciences-focused investment fund for the sale of 748,744 shares of its common stock, pre-funded warrants exercisable for an aggregate of 2,632,898 shares of common stock and common warrants exercisable for an aggregate of 4,227,052 sha

  • Insider Monkey

    10 Cheapest Stocks With Biggest Upside

    In this article, we discuss the 10 cheapest stocks with the biggest upside. If you want to read about some more cheapest stocks with the biggest upside, go directly to 5 Cheapest Stocks With Biggest Upside. According to the advance estimate released by the Bureau of Economic Analysis in late October 2022, the real gross […]